MIMS news

Prescribers alerted to topical steroid withdrawal reactions

Prescribers alerted to topical steroid withdrawal reactions

The MHRA has issued advice for prescribers to minimise...

SGLT2 inhibitors backed for cardiovascular prevention in draft NICE guidance

SGLT2 inhibitors backed for cardiovascular prevention in draft NICE guidance

SGLT2 inhibitors should be considered as first-line...

'Game-changing' new cholesterol-lowering drug to be given by GPs

'Game-changing' new cholesterol-lowering drug to be given by GPs

Draft guidance from NICE recommends inclisiran (Leqvio)...

New triple combination dry powder inhaler launched for COPD

New triple combination dry powder inhaler launched for COPD

Trimbow NEXThaler is a breath-actuated dry powder inhaler...

Flu vaccines updated for 2021/22 season

Flu vaccines updated for 2021/22 season

Up-to-date information for the influenza vaccines recommended...

Sustainable inhaler prescribing incentive announced

Sustainable inhaler prescribing incentive announced

NHS England has introduced a new target for practices...

Branded generic of Fostair 100/6 pMDI launched for asthma and COPD

Branded generic of Fostair 100/6 pMDI launched for asthma and COPD

Luforbec 100/6 pressurised metered dose inhaler (pMDI)...

New warning for AstraZeneca COVID-19 vaccine

New warning for AstraZeneca COVID-19 vaccine

A warning about Guillain-Barré syndrome has been added...

New shingles vaccine to be rolled out next month

New shingles vaccine to be rolled out next month

Shingrix should be offered to immunocompromised patients...

Moderna COVID-19 vaccine approved in adolescents

Moderna COVID-19 vaccine approved in adolescents

The Moderna COVID-19 vaccine, now known as Spikevax,...

Irbesartan batches recalled over contamination

Irbesartan batches recalled over contamination

Batches of some irbesartan-containing products are...

Second SGLT2 inhibitor approved for heart failure

Second SGLT2 inhibitor approved for heart failure

Clinicians now have a choice of SGLT2 inhibitors to...

SGLT2 inhibitor licensed to treat chronic kidney disease

SGLT2 inhibitor licensed to treat chronic kidney disease

Forxiga (dapagliflozin) can now be prescribed to treat...

Third tiotropium inhaler adds to treatment options for COPD patients

Third tiotropium inhaler adds to treatment options for COPD patients

Tiogiva is a new breath-actuated inhaler containing...

New shingles vaccine awaits decision on NHS use

New shingles vaccine awaits decision on NHS use

Shingrix, which is now available privately in the UK,...

Compare COVID-19 vaccines with new MIMS table

Compare COVID-19 vaccines with new MIMS table

Key characteristics of available COVID-19 vaccines...

C. difficile treatment guidance published by NICE

C. difficile treatment guidance published by NICE

NICE has issued antimicrobial prescribing guidance...

New contraindication for AstraZeneca COVID-19 vaccine

New contraindication for AstraZeneca COVID-19 vaccine

The AstraZeneca COVID-19 vaccine, now known as Vaxzevria,...

Muscle relaxants 'ineffective' for low back pain

Muscle relaxants 'ineffective' for low back pain

Muscle relaxant drugs are largely ineffective for low...

Chloramphenicol eye drops safe for under 2s, says MHRA

Chloramphenicol eye drops safe for under 2s, says MHRA

The balance between the benefits and risks of chloramphenicol...